144 related articles for article (PubMed ID: 37089260)
1. A 20-Gene Signature Predicting Survival in Patients with Clear Cell Renal Cell Carcinoma Based on Basement Membrane.
Yin Z; Zhao Y; Zhou W; You C; Bai Y; You B; Lu D; Liao S; Zheng L; Sun Y; Wu Y
J Oncol; 2023; 2023():1302278. PubMed ID: 37089260
[TBL] [Abstract][Full Text] [Related]
2. Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients.
Tao J; Li X; Liang C; Liu Y; Zhou J
Front Oncol; 2022; 12():1026331. PubMed ID: 36353536
[TBL] [Abstract][Full Text] [Related]
3. A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Peng L; Liang J; Wang Q; Chen G
Front Genet; 2022; 13():798846. PubMed ID: 35656315
[No Abstract] [Full Text] [Related]
4. Integration of basement membrane-related genes in a risk signature for prognosis in clear cell renal cell carcinoma.
Xia B; Wang J; Zhang D; Hu X
Sci Rep; 2024 Feb; 14(1):3893. PubMed ID: 38365923
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
[TBL] [Abstract][Full Text] [Related]
6. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
7. A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma.
Zhou T; Chen W; Wu Z; Cai J; Zhou C
Front Genet; 2022; 13():994208. PubMed ID: 36186476
[No Abstract] [Full Text] [Related]
8. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
9. Identification of a basement membrane-based risk scoring system for prognosis prediction and individualized therapy in clear cell renal cell carcinoma.
Tang Y; Ye C; Zeng J; Zhu P; Cheng S; Zeng W; Yang B; Liu Y; Yu Y
Front Genet; 2023; 14():1038924. PubMed ID: 36816030
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
11. Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.
Wu X; Xie W; Gong B; Fu B; Chen W; Zhou L; Luo L
Front Oncol; 2023; 13():1124080. PubMed ID: 36776317
[TBL] [Abstract][Full Text] [Related]
12. Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma.
Cheng X; Deng W; Zhang Z; Zeng Z; Liu Y; Zhou X; Zhang C; Wang G
Front Genet; 2022; 13():982162. PubMed ID: 36118874
[No Abstract] [Full Text] [Related]
13. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
Front Genet; 2022; 13():1039465. PubMed ID: 36338978
[No Abstract] [Full Text] [Related]
14. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
15. A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma.
Lin MJ; Tang XX; Yao GS; Tan ZP; Dai L; Wang YH; Zhu JQ; Xu QH; Mumin MA; Liang H; Wang Z; Deng Q; Luo JH; Wei JH; Cao JZ
Front Pharmacol; 2023; 14():1120562. PubMed ID: 37021054
[No Abstract] [Full Text] [Related]
16. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y
Front Genet; 2022; 13():787884. PubMed ID: 35350243
[No Abstract] [Full Text] [Related]
17. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
18. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X
BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
